I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AMCP Nexus 2026

-
11:30 PM
Duration 3mins San Diego, USA
Healthcare resource utilization and costs associated with teprotumumab in moderate-to-severe thyroid eye disease
Stella Ko, Achal Patel, Nicole Gidaya Bonine, Ayesha Ahmed, Madhura Tamhankar
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 29mins San Diego, USA
Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Functional and Safety Outcomes up to 3 Years Post-Infusion in the EMBARK Study
Jerry R. Mendell, Francesco Muntoni, Craig M. McDonald, Eugenio M. Mercuri, Emma Ciafaloni, Hirofumi Komaki, Carmen Leon-Astudillo, Andrés Nascimento, Crystal Proud, Ulrike Schara-Schmidt, Aravindhan Veerapandiyan, Craig M. Zaidman, Matthew Furgerson, Mark Vivien, Damon R. Asher, Alexander P. Murphy, Marianne Gerber, Carmen O. Torre, Marianna Manfrini, Louise R. Rodino-Klapac
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 29mins San Diego, USA
Pooled Safety Analysis from Phase 1 to Phase 3 Clinical Trials of Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy
Crystal Proud, Craig M. McDonald, Eugenio M. Mercuri, Francesco Muntoni, Craig M. Zaidman, Vannary Pizzo, Matthew Furgerson, Jim Jin, Alexander P. Murphy, Mark Vivien, Marianne Gerber, Jerry R. Mendell
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 29mins San Diego, USA
Delandistrogene moxeparvovec micro-dystrophin expression and safety in 2-3-year-olds with Duchenne muscular dystrophy in ENDEAVOR and ENVOL studies
Craig M. McDonald, Francesco Muntoni, Andrea Gangfuss, Crystal Proud, Craig M. Zaidman, Laurent Servais, Anne M. Connolly, Patsy Thrasher, Mark Vivien, Alex Haile, Jennifer Thomas-Ahner, Jianfeng Meng, Alexander P. Murphy, Becca B. Zhang, Ewa Karasek, Pooneh Pordeli, Louise R. Rodino-Klapac
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:00 PM
Duration 60mins San Diego, USA
Evaluating Price Controls and Patient Affordability: Lessons From the Historical PCSK9 Price Reductions and Medicare Part D Formularies
Danny Sheinson, William B Wong
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins San Diego, USA
Does Copay Assistance Affect the Likelihood of a Successful Appeal of a Rejection Due to Utilization Management?
Thomas Majda, Danny Shienson, Anna Hung, William B Wong
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins San Diego, USA
Indirect Comparison of Afimkibart and Adalimumab Treatment Effects Using Data From TUSCANY-2 and HIBISCUS in Patients With Ulcerative Colitis
Rami Rihani, Steven Levitte, Qixiang Xu, Vishal A. Manickam, Yihao Li, Jiameng Zhang, Anindita Banerjee, Deepa E. Chandra, Elena Peeva, Srividya Neelakantan, Michael S. Vincent, K. T. Park
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins San Diego, USA
Real-World Treatment Patterns in Patients With Moderate to Severe Ulcerative Colitis in the United States
Shelia Shapouri, Achal Patel, Robert Schuldt, Tara Fehlmann, Ben Kostiuk, Nikki Win, Norelle Reilly, Oliwia Zurek
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon